This article relies largely or entirely on a single source. Relevant discussion may be found on the talk page. Please help improve this article by introducing citations to additional sources. Find sources: "Trisescaline" – news · newspapers · books · scholar · JSTOR (August 2019) |
Pharmaceutical compound
| Clinical data | |
|---|---|
| Other names | Trescaline; 3,4,5-Triethoxyphenethylamine |
| Routes of administration | Oral[1] |
| ATC code |
|
| Pharmacokinetic data | |
| Duration of action | Unknown[1] |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider |
|
| UNII | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C14H23NO3 |
| Molar mass | 253.342 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| | |
Trisescaline, or trescaline, also known as 3,4,5-triethoxyphenethylamine, is a lesser-known phenethylamine prepared as a possible psychedelic drug. It is an analog of mescaline. Trisescaline was first synthesized by Alexander Shulgin. In his book PiHKAL, both the minimum dosage and the duration are unknown.[1] Trisescaline produces no effects. Very little data exists about the pharmacological properties, metabolism, and toxicity of trisescaline.
See also
References
- 1 2 3 Shulgin A, Shulgin A (September 1991). PiHKAL: A Chemical Love Story. Berkeley, California: Transform Press. ISBN 0-9630096-0-5. OCLC 25627628. "Trisescaline entry".
This psychoactive drug-related article is a stub. You can help Wikipedia by expanding it. |